Course: Advanced Pharmacology

Exam (elaborations) Dec 16, 2025 ★★★★★ (5.0/5)
  • This is the latest version of the study guides, questions, and answers.
  • Immediately available for download right after your purchase.
  • Carefully curated content designed to help you prepare effectively.

Document Text

Chamberlain University

NR 546 / NR546

Week 5 Antidepressant Medications Table

Course: Advanced Pharmacology

  • / 3

Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life

(T1/2)

CYP450

enzyme Notes/Notable side effects/Precautions SSRIs Citalopram (Celexa) •Target symptoms •Depressed mood •Anxiety •Panic attacks, avoidant behavior, reexperiencing, hyperarousal •Sleep disturbance, insomnia and hypersomnia Indication •Depression

•PMDD

•OCD

•Panic d/o

•GAD

•PTSD

•Social anxiety d/o Neurotransmitter •Serotoni n •Weak inhibitor of

CYP450

2D6 Metabolized by CYPf450 3A4 and 2C19 Half-life 23-45 hour

CYP450

• • Rare seizures, induction of mania, activation of suicidal ideation Sexual dysfunction •Decreased appetite, n/d, constipation, dry mouth •Dose dependent insomnia, sedation, agitation, tremors, headache,dizzy •Pt with bipolar or psychotic d/o may be more vulnerable to CNS-activating actions of SSRIs •Sweating •Bruising and rare bleeding •Rare hyponatremia •Syndrome of inappropriate antidiuretic hormone Escitalopram (Lexapro) Target symptoms •Depressed mood •Anxiety •Panic attacks, Half-life 27-32 hours

CYP450

Substrate for •Sexual dysfunction ED, delayed ejaculation, decreased sexual desire, anorgasmia •Decreased appetite, n/d, constipation, dry mouth •Insomnia and sedation, agitation, tremors, Downloaded by Benjamin Luca ([email protected]) lOMoARcPSD 51648332 2 / 3

avoidant behavior, reexperiencing, hyperarousal •Sleep disturbance, insomnia and hypersomnia Indication

•MDD 12+

•GAD

•Panic d/o

•OCD

•PTSD

•Social anxiety d/o

•PMDD

Neurotransmitter •Serotonin CYP450 and 3A4 No significant actions on CYP450 enzymes headache, dizzy •Pt with bipolar or psychotic d/o may be more vulnerable to CNS-activating actions of SSRIs •Sweating •Rare hyponatremia Syndrome of inappropriate antidiuretic hormone secretion •Rare seizures, induction of mania, activation of suicidal ideation Downloaded by Benjamin Luca ([email protected]) lOMoARcPSD 51648332

  • / 3

User Reviews

★★★★★ (5.0/5 based on 1 reviews)
Login to Review
S
Student
May 21, 2025
★★★★★

This document provided in-depth analysis, which made learning easy. Absolutely impressive!

Download Document

Buy This Document

$35.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: Exam (elaborations)
Added: Dec 16, 2025
Description:

Chamberlain University NR 546 / NR546 Week 5 Antidepressant Medications Table Course: Advanced Pharmacology Antidepressant Medications Name Indication, starting dose, target symptoms, and affected ...

Unlock Now
$ 35.00